What Is Cerebrolysin? Dosage, Half-Life & How to Track It

What Cerebrolysin is and how it works

Cerebrolysin isn’t a single peptide the way BPC-157 or Semax are — it’s a preparation, made by enzymatically breaking down purified porcine brain protein into a mixture of low-molecular-weight peptide fragments and free amino acids, small enough to cross the blood–brain barrier. It has been manufactured and used clinically (via IV or IM infusion) in parts of Europe, Asia, and Latin America for decades, primarily for stroke and vascular dementia, though it is not approved by the FDA for any use in the US.

Its proposed mechanism is to mimic the action of the brain’s own growth factors — particularly NGF (nerve growth factor) and BDNF (brain-derived neurotrophic factor) — supporting neuron survival, while also dampening the neuroinflammatory response that follows an injury like a stroke. Because it is a heterogeneous mixture rather than one defined molecule, its full mechanism is harder to pin down than a single-sequence peptide’s.

The clinical evidence base is real but mixed — several trials outside the US report benefit in stroke recovery and dementia, while others (including some larger ones) have failed to replicate the effect clearly enough for US approval. Treat outcomes as genuinely contested rather than settled either way, and note that clinical dosing there is IV/IM infusion, not the subcutaneous protocol below.

Typical dosing & reconstitution

The subcutaneous protocol below is a conservative adaptation of clinical dosing for people using a lyophilized research vial rather than a commercial ampoule — clinical IV regimens have used doses as high as 215 mg/day, far beyond what is practical or advisable subcutaneously. Reconstituted with bacteriostatic water, a common approach starts at 20 mg once daily, stepping up over four weeks to 32 mg/day, split into AM/PM injections once the daily amount exceeds 20 mg (more than 1 mL on a standard insulin syringe).

A 60 mg vial reconstituted with 3 mL BAC water gives 20 mg/mL — here’s how a gradual titration maps to units:

At 20 mg/mL, doses above 20 mg (100 units) exceed a standard 1 mL insulin syringe and are split across two injections. The reconstitution calculator handles the concentration math for whatever vial and water you actually have.

Half-life & what it means for frequency

Because Cerebrolysin is a mixture of many different peptide fragments and free amino acids rather than one molecule, it doesn’t have a single half-life the way BPC-157 or a testosterone ester does — each component is metabolized on its own short timeline, generally minutes to a couple of hours, similar to how the body clears other small peptides and amino acids.

That short, fragmented clearance is the practical reason it is dosed daily (split into two injections at higher doses) rather than weekly — there is no long-acting component to build a depot or accumulate blood levels the way a longer peptide or ester would.

What to track & common side effects

Reported side effects in clinical use include injection-site irritation, headache, dizziness, and occasionally agitation or restlessness, especially early in titration. Because it is derived from animal (porcine) protein, allergic reactions are a real, if uncommon, consideration — a new or unusual reaction after a dose is worth stopping and asking a doctor about.

What’s worth tracking is the titration week you’re on (the dose changes every week for the first month), the AM/PM split once you’re above 20 mg, and whatever cognitive or recovery marker motivated using it in the first place — since that trend, not any single day, is the actual signal.

Frequently asked questions